I was diagnosed with Gleason 8 and coupled with high PSA and family history I was considered "high risk". I belive your husband is high risk as well. I was offered two clinical trials, both designed to reduce the probability of recurrence. The hypothesis is that the reason high risk cancers recurr even when confined to prostate is the micro mets. The systemic treatment to kill cancer is thought to kill those and to make the surgery easier by reducing the tumor size. First trial was a stage 3 trial of HT plus Taxotere, the second was stage 2trial of Taxotere plus Avastin, a drug to prevent formation of capilars that feed tumors.
The HT plus Taxotere stage 2 trial that was finished by then had two people whose cancer was completely gone from the prostate.
While what you are describing is different, I think the motivation is similar.
I join others in sugesting you seek multiple opinions, but do go and listen what the Eldorado people have to say. If nothing else, they will give you more questions to ask other docs.
Best of luck in your search for the treatment. Stay cool. This is not the end of the world.
Father died from poorly differentiated PCa @ 78 - normal PSA and DRE
5 biopsies over 4 years negative while PSA going from 3.8 to 28
Dx Nov 2007, age 46, PSA 29, Gleason 4+4=8
Decided to participate in clinical trial at Duke - 6 rounds of chemo (Taxotere+Avastin)
PSA prior to treatment on 1/8/2008 is 33.90, bounced on 1/31/2008 to 38.20, and down at the end of the treatment (4/24/2008) to 20.60
RRP at Duke (Dr. Moul) on 6/16/2008, Gleason downgraded 4+3=7, T3a N0MX, focal extraprostatic extension, two small positive margins
PSA undetectable for 8 months, then 2/6/2009-0.10, 4/26/2009-0.17, 5/22/2009-0.20, 6/11/2009-0.27
Salvage IMRT + 6 Months ADT: Casodex started 6/12/2009, Lupron 6/22/2009, PSA 6/25/2009-0.1, T=516, 7/23/2009-<0.05, T<10, IMRT to start mid-Aug